Serial 87177927
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 13 Nov 2023)
What this means for you
Registered since 05 Dec 2017. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 87177927
- Registration number
- 5351676
- Mark type
- Design / logo
- Filed
- 21 Sept 2016
- Published for opposition
- 31 Jan 2017
- Registered
- 05 Dec 2017
- Attorney of record
- Cheryl L. Foytlin
Goods and services
- Class 005 — Pharmaceuticals: Human pharmaceutical preparations for the prevention and treatment of auto-immune and inflammatory diseases, immunological diseases and dermatologic diseases
Owner
- Johnson & Johnson, New Brunswick, NJ, US
- Johnson & Johnson, New Brunswick, NJ, US
- Johnson & Johnson, New Brunswick, NJ, US
Prosecution history
- 13 Nov 2023 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 13 Nov 2023 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 13 Nov 2023 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 15 May 2023 — TEAS SECTION 8 & 15 RECEIVED
- 05 Dec 2022 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 05 Dec 2017 — REGISTERED-PRINCIPAL REGISTER
- 31 Oct 2017 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 30 Oct 2017 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 06 Oct 2017 — STATEMENT OF USE PROCESSING COMPLETE
- 27 Sept 2017 — USE AMENDMENT FILED
- 04 Oct 2017 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 27 Sept 2017 — TEAS STATEMENT OF USE RECEIVED
- 28 Mar 2017 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 31 Jan 2017 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 31 Jan 2017 — PUBLISHED FOR OPPOSITION